-

Evvy Launches Women’s Complete Probiotic, Delivering Advanced 3-in-1 Microbiome Support for Gut, Urinary, & Vaginal Health

Developed by the scientists behind Evvy’s Vaginal Microbiome Test, the unique formulation offers targeted support for women’s interconnected microbiomes

NEW YORK--(BUSINESS WIRE)--Evvy, the precision women’s health company, today announces the launch of its latest innovation: Evvy Women’s Complete Probiotic. This once-daily supplement delivers advanced 3-in-1 microbiome support for gut, vaginal and urinary health — backed by science and uniquely formulated for women.

Unlike most probiotics that target just one area of health, Evvy Women’s Complete Probiotic is designed to support the full microbiome ecosystem that shapes a woman's wellbeing. The probiotic includes:

  • Clinically-studied Lactobacillus strains to promote healthy bacteria, support yeast balance, and reduce bloating
  • Patented delayed-release capsules that increase survivability of probiotic strains through the GI tract
  • Postbiotics and Vitamins D & E to support immunity and gut barrier integrity

“At Evvy, our research across over 50,000 women has shown just how deeply interconnected the gut, urinary, and vaginal microbiomes are — yet most products continue to treat them in isolation,” said Pita Navarro, Co-founder and Chief Science Officer at Evvy. “That’s why we created a formulation that finally reflects the science: a single research-backed capsule that supports the full picture of women’s microbiome health.”

The launch of the Women’s Complete Probiotic builds on Evvy’s pioneering vaginal healthcare platform, which includes the world’s first at-home Vaginal Microbiome Test powered by metagenomic sequencing, as well as precision prescription treatments. Informed by insights from the largest real-world dataset on the vaginal microbiome, Evvy Women’s Complete Probiotic is designed as a proactive daily essential for supporting gut, urinary, and vaginal health.

The Women’s Complete Probiotic is available for $55 for a monthly supply of 30 capsules or $44/month with a subscription. To learn more visit, evvy.com/womens-complete-probiotic.

About Evvy:

Founded in 2021, Evvy is closing the gender health gap by leveraging overlooked female biomarkers, starting with the vaginal microbiome. The company offers the world’s first Vaginal Microbiome Test powered by metagenomic sequencing, analyzing over 700 microbes with a single, at-home swab — including those related to bacterial vaginosis, yeast infections, fertility outcomes, and more. Evvy’s care platform also includes precision treatment pathways from licensed clinicians and 1:1 health coaching. Through their test and care platform, Evvy has built the world’s largest dataset on the vaginal microbiome, and they are leveraging this novel data to improve outcomes across women’s health.

Contacts

Media Contact:
Jess Bryant
SolComms
evvy@solcomms.co

Evvy


Release Versions

Contacts

Media Contact:
Jess Bryant
SolComms
evvy@solcomms.co

More News From Evvy

Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health

NEW YORK--(BUSINESS WIRE)--Evvy, the pioneering precision medicine company for women’s health, today announced an oversubscribed $40 million Series B led by Catalio Capital Management. Since its founding in 2021, the company has built the world's largest proprietary, clinical-grade dataset on the vaginal microbiome and women's health outcomes — and the machine learning engine, EvvyAI, that interprets large-scale biological data to transform patient care. This round will fund the validation of a...

Evvy Launches EvvyAI: The First AI Advisor for Vaginal Health Built on the World's Largest Vaginal Microbiome Dataset

NEW YORK--(BUSINESS WIRE)--Evvy, the precision women's health company, today announces the launch of EvvyAI: an AI advisor that translates Evvy's proprietary vaginal microbiome science into personalized, real-time guidance for every user. Vaginal discomfort is one of the leading reasons women seek healthcare advice — yet the information available remains fragmented and unreliable. Women navigating chronic infections, fertility, and menopause are left sorting through generic clinical guidance, u...

Evvy Unveils Data-Driven Subtypes of Bacterial Vaginosis

NEW YORK--(BUSINESS WIRE)--Evvy, the precision women’s health company, today announced new data showing that bacterial vaginosis (BV) encompasses multiple distinct microbial subtypes, rather than a single uniform biological state. While Evvy-affiliated clinicians continue to diagnose BV using established clinical criteria, these findings provide a comprehensive, microbiome-level context for patients and their clinicians, shining a light on the underlying biology behind a patient’s diagnosis. BV...
Back to Newsroom